46 results on '"Retterstøl K"'
Search Results
2. Intake of a protein-enriched milk and effects on muscle mass and strength. A 12-week randomized placebo controlled trial among community-dwelling older adults
3. Vascular risk factors, vascular disease, lipids and lipid targets in patients with familial dysbetalipoproteinemia: A European cross-sectional study
4. Female patients with familial hypercholesterolemia have higher cholesterol burden at 19 and 30 years of age: Data from 12-years follow-up
5. LDL-c response with different statin treatment intensities in fh patients: A sex-specific analysis
6. No increased risk of stroke in genetically verified familial hypercholesterolemia: A prospective matched cohort study
7. Unchanged hazard ratios of incident acute myocardial infarction in patients with Familial Hypercholesterolemia during 2001-2017
8. Registry data indicate higher risk of eating disorders in individuals with familial hypercholesterolemia compared with age and sex matched controls
9. Diabetes in patients with genetically verified familial hypercholesterolemia
10. Risks associated with use of statins and other lipid-modifying agents across pregnancy – A nationwide drug safety study in Norway in 2005-2018
11. Risk of cardiovascular disease in patients with genetically verified familial hypercholesterolemia and mental illness
12. Maternal use of statins in pregnancy: A population-based registry study
13. Event-free FH patients >65 years of age are characterized by higher concentration of large HDL particles
14. Children with familial hypercholesterolemia display changes in LDL and HDL function: A Cross-sectional study
15. Twenty-five percent of children with familial hypercholesterolemia treated with statins have compliance issues
16. Quantitative assessment of the lifelong, substantial increased risk of coronary revascularization in familial hypercholesterolemia
17. No increased risk of cognitive impairment in familial hypercholesterolemia compared with controls
18. Higher Expression Of Genes Related To T- And B-Cell Pathways In Pbmcs From Children With Versus Without Familial Hypercholesterolemia: A Cross-Sectional Study
19. Exploring The Effect Of Using Heart Age In A Community-Pharmacy Setting: A Four-Week Cluster-Randomized Controlled Trial
20. Treat-to-target familial hypercholesterolemia (TTT-FH): a prospective study in adult patients with FH. Women have many years off lipid lowering medication due to pregnancy
21. Excess risk of peripheral arterial disease in familial hypercholesterolemia
22. The impact of age and sex on excess risk of coronary heart disease in patients with familial hypercholesterolemia: A registry study
23. The excess risk of hospitalization for aortic aneurism in patients with familial hypercholesterolemia: A registry study
24. The role of ldl cholesterol on excess risk of aortic stenosis: A registry study
25. Treat-to-target familial hypercholesterolemia (TTT-FH): A prospective study in adult patients with FH. Results after long term intensive lipid lowering treatment in a specialized lipid clinic
26. Secular trends in serum lipids in Norway, 2000-2016
27. High lipoprotein (A) levels do not exacerbate aortic valve velocity in a group of fh subjects
28. Elevated LDL cholesterol from birth is associated with different risk of various types of atherosclerotic disease
29. PT02.6: Intake of a Protein-Enriched Milk and Effects on Muscle Mass and strength. A 12-week Randomized Placebo Controlled Trial Among Community-Dwelling Elderly
30. Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia
31. Mortality of cardiovascular disease in patients with genetically verified familial hypercholesterolemia
32. Improved health outcomes by indentifying high cardiovascular risk individuals in a pharmacy setting – A randomized controlled trial
33. Intake of oxidised fish oil does not affect circulating levels of oxidised LDL or inflammatory markers in healthy subjects
34. 764 OCCURRENCE OF CORONARY HEART DISEASE IN A COHORT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS IN NORWAY
35. 275 HEALTH EFFECTS OF OXIDIZED COD LIVER OIL IN HEALTHY SUBJECTS: A RANDOMIZED CONTROLLED TRIAL
36. 69 HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN NORWAY, SWEDEN, DENMARK AND FINLAND – SUBSTANTIAL VARIATION IN FREQUENCY OF THE DIAGNOSIS
37. P76 PREGNANCY OUTCOMES IN FAMILIAL HYPERCHOLESTEROLEMIA WITH SPECIAL EMPHASIS ON PRETERM DELIVERY, BIRTH WEIGHT AND CONGENITAL MALFORMATIONS. A REGISTRY-BASED STUDY
38. P238 Efficacité et tolérance de l’association fénofibrate 160 mg/pravastatine 40 mg chez des patients diabétiques de type 2 en prévention primaire et avec hypercholestérolémie mixte
39. Abstract: P1366 WILD SCREENING FOR HIGH PLASMA CHOLESTEROL IN PUBLIC AREAS
40. Abstract: P683 ACTIVATION OF THE TNFA INFLAMMATORY SYSTEM IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA
41. Abstract: 102 THE EFFECT OF Q10 AND SELENIUM SUPPLEMENT ON ADVERSE EFFECTS IN STATIN TREATMENT
42. ROSUVASTATIN REDUCES NON-HDL-CHOLESTEROL AND LIPOPROTEIN REMNANTS IN FREDRICKSON TYPE III HYPERLIPOPROTEINAEMIA PATIENTS
43. 38 Development of a procoagulant pattern during pregnancy among women with familial hypercholesterolemia
44. Th-P16:266 The effect of red yeast rice on lipids, inflammatory markers and glucose in subjects with mild hypercholesterolemia and mildly elevated blood glucose
45. Compliance of long-term lipid-lowering therapy in familial hypercholesterolemia, influence on life quality and progression of coronary heart disease
46. N-terminal proatrial natriuretic factor (pro-ANF) and familial hypercholesterolemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.